Search

everythinglearnresearchcommunity

for

Search:↓

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

A Japanese patient with IFAP syndrome had a severe MBTPS2 gene mutation but showed milder symptoms than previously observed cases.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Polycystic ovarian disease symptoms can continue after menopause, making diagnosis and management in older women challenging.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Looking older on the outside might be linked to aging faster on the inside and can be affected by lifestyle choices and health risks.

Vitamin E helps reduce PCOS symptoms and improves hormonal balance.

Early hair loss common in Chinese males, linked to family history and smoking; early treatment advised.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Piezoelectric Nanogenerators are promising for non-invasive health monitoring but need efficiency and durability improvements.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.